Cargando…
Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer
BACKGROUND: Over the past decade, oncology therapies have trended toward orally administered regimens, and there has been growing attention on evaluation of factors that affect adherence. There has not been a rigorous investigation of factors associated with adherence to intravenous (IV) and oral an...
Autores principales: | Seal, Brian S., Anderson, Sibyl, Shermock, Kenneth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397912/ https://www.ncbi.nlm.nih.gov/pubmed/27003552 http://dx.doi.org/10.18553/jmcp.2016.22.3.227 |
Ejemplares similares
-
The effects of oral anticancer parity laws on out-of-pocket spending and adherence among commercially insured patients with chronic myeloid leukemia
por: Spargo, Andrew, et al.
Publicado: (2021) -
Sequential Therapies and the Cost-Effectiveness of Treating Metastatic Colon Cancer Patients
por: Woldemichael, Andinet, et al.
Publicado: (2016) -
Oral anticancer agent medication adherence by outpatients
por: KIMURA, MICHIO, et al.
Publicado: (2014) -
Provider‐ and patient‐level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinoma
por: Spees, Lisa P., et al.
Publicado: (2021) -
Comparing and validating medication complexity from insurance claims against electronic health records
por: Kitchen, Christopher A, et al.
Publicado: (2022)